{"id":56482,"date":"2023-05-03T12:05:39","date_gmt":"2023-05-03T10:05:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/"},"modified":"2023-05-03T12:05:39","modified_gmt":"2023-05-03T10:05:39","slug":"uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/","title":{"rendered":"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin\u00ae<\/sup> blood culture collection sets, announced today that the US Patent and Trademark Office has granted Kurin\u2019s Ex Parte request to reexamine the validity of U.S. Patent No. 10,039,483 (the \u2018483 patent) that is asserted by Magnolia Medical in ongoing patent litigation. The Examiner noted there were multiple \u201cSubstantial New Questions of Patentability\u201d that merit review.<\/p>\n

<\/a><\/p>\n

\n\u201cWe are pleased that the Examiner has agreed to the review of the patentability of the relevant claims in the \u2018483 patent,\u201d said Bob Rogers, CEO of Kurin, Inc. \u201cMagnolia originally asserted four patents, then dropped the others leaving just the \u2018483 patent for trial. The prior art that was not previously considered raises serious questions about the validity of the \u2018483 patent and would therefore have significant impact on Magnolia\u2019s efforts to prevent access to the Kurin Lock.\u201d<\/p>\n

\n\u201cWe look forward to the resolution of this matter. We continue to believe this litigation was a bullying attempt by Magnolia to try to address its inability to compete fairly with the smaller and more user-friendly Kurin device.\u201d<\/p>\n

\nKurin\u2019s revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and life-threatening C. diff.<\/i> infections.<\/p>\n

\nAbout Kurin, Inc.<\/strong><\/p>\n

\nKurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMatt Heindel
\n
Kurin, Inc.
\n
858-752-9514
\n
mattheindel@kurin.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin\u00ae blood culture collection sets, announced today that the US Patent and Trademark Office has granted Kurin\u2019s Ex Parte request to reexamine the validity of U.S. Patent No. 10,039,483 (the \u2018483 patent) that is asserted by Magnolia Medical in ongoing patent litigation. The Examiner noted … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56482","6":"format-standard","7":"category-industry"},"yoast_head":"\nUSPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin\u00ae blood culture collection sets, announced today that the US Patent and Trademark Office has granted Kurin\u2019s Ex Parte request to reexamine the validity of U.S. Patent No. 10,039,483 (the \u2018483 patent) that is asserted by Magnolia Medical in ongoing patent litigation. The Examiner noted ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-03T10:05:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230503005149\/en\/1781152\/21\/KurinLOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent\",\"datePublished\":\"2023-05-03T10:05:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/\"},\"wordCount\":346,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230503005149\\\/en\\\/1781152\\\/21\\\/KurinLOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/\",\"name\":\"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230503005149\\\/en\\\/1781152\\\/21\\\/KurinLOGO.jpg\",\"datePublished\":\"2023-05-03T10:05:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230503005149\\\/en\\\/1781152\\\/21\\\/KurinLOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230503005149\\\/en\\\/1781152\\\/21\\\/KurinLOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/","og_locale":"en_US","og_type":"article","og_title":"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin\u00ae blood culture collection sets, announced today that the US Patent and Trademark Office has granted Kurin\u2019s Ex Parte request to reexamine the validity of U.S. Patent No. 10,039,483 (the \u2018483 patent) that is asserted by Magnolia Medical in ongoing patent litigation. The Examiner noted ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/","og_site_name":"Pharma Trend","article_published_time":"2023-05-03T10:05:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230503005149\/en\/1781152\/21\/KurinLOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent","datePublished":"2023-05-03T10:05:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/"},"wordCount":346,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230503005149\/en\/1781152\/21\/KurinLOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/","url":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/","name":"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230503005149\/en\/1781152\/21\/KurinLOGO.jpg","datePublished":"2023-05-03T10:05:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230503005149\/en\/1781152\/21\/KurinLOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230503005149\/en\/1781152\/21\/KurinLOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/uspto-agrees-to-kurins-request-to-review-validity-of-magnolia-medicals-483-patent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"USPTO Agrees to Kurin\u2019s Request to Review Validity of Magnolia Medical\u2019s \u2018483 Patent"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56482"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56482\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}